Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location |
|---|---|---|---|
Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy |
Atypical Hemolytic Uremic Syndrome | Phase 3 | United States Greece China Brazil Slovakia Japan India Austria Slovenia United Kingdom Czech Republic Korea, Republic of Taiwan View All |
Study of Efficacy, Safety and Tolerability of DFV890 in Patients With Knee Osteoarthritis |
Symptomatic Knee Osteoarthritis | Phase 2 | United States Germany Czech Republic Romania Hungary Argentina Spain Slovakia View All |
STIMULUS MDS-US : Sabatolimab Added to HMA in Higher Risk MDS |
Myelodysplastic Syndrome (MDS) | Phase 2 | United States |
Asciminib Roll-over Study |
Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Phase 4 | United States Spain Germany France Czech Republic Argentina Denmark Portugal Italy Mexico Canada Russian Federation United Kingdom Brazil Turkey Romania Bulgaria Poland Austria View All |
A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors |
Mesothelioma | Phase 1 | United States Spain Japan Germany United Kingdom Australia Italy Canada Netherlands France Switzerland View All |
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy. |
C3G | Phase 3 | Turkey Japan Greece United States Spain Brazil Switzerland Argentina Germany United Kingdom France Canada India Israel Czech Republic Italy View All |
Study of Efficacy and Safety of Eltrombopag in Lower-risk MDS Patients With Platelet Transfusion Dependence |
Myelodysplastic Syndromes | Phase 2 | Japan |
Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS |
Multiple Sclerosis | Phase 3 | France Spain Germany Italy View All |
Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria |
Paroxysmal Nocturnal Hemoglobinuria | Phase 3 | United States Italy Taiwan Turkey Malaysia United Kingdom France Korea, Republic of Singapore Germany Lithuania View All |
Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins. |
Glioblastoma Multiforme, Brain Neoplasms, Gastroesophageal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma | Early Phase 1 | Germany |